Cora or Ro Body? A 2026 GLP-1 cost breakdown

Cora Health vs Ro: the short answer

Cora Health and Ro (Ro Body) are both US telehealth platforms that connect patients with licensed providers for GLP-1 weight loss treatment, though as of July 2026 they no longer compete in the same medication category — Ro fully exited compounded semaglutide and tirzepatide earlier in 2026 and now sells only FDA-approved branded GLP-1s. Cora Health charges a single all-inclusive monthly price — $120/month on the 6-month Essential Plan for compounded semaglutide — that covers provider consultation, medication from Hallandale Pharmacy or VialsRx, shipping, and ongoing monitoring. Ro uses a two-part structure: a Ro Body Membership ($39 first month, $149/month thereafter) plus separate branded-medication costs (Wegovy pill from $149/month, Wegovy pen from $199/month, Zepbound from $299/month, each rising with dose). For a patient on Ro’s entry-level Wegovy pill, the effective total is roughly $298/month — about 148% more than Cora’s all-inclusive $120 for compounded semaglutide, with the added distinction that Ro’s product is FDA-approved and Cora’s is not. Ro’s advantages are broader medication access (FDA-approved brand-name Wegovy injection and pill, Zepbound) and nationwide availability across all 50 states. Cora Health’s advantages are lower total monthly cost on compounded treatment, publicly named 503A pharmacy partner, and LegitScript certification.

Market context: where Cora and Ro Body sit in the 2026 GLP-1 telehealth market

Four numbers anchor the head-to-head comparison between Cora Health and Ro Body in 2026:

41.9% — US adult obesity prevalence. Per the Centers for Disease Control and Prevention (CDC), using NHANES 2017–March 2020 data, 41.9% of US adults have obesity (BMI ≥ 30) — the population for whom GLP-1 telehealth was built. The CDC notes that "obesity-related conditions include heart disease, stroke, type 2 diabetes, and certain types of cancer, [which] are among the leading causes of preventable, premature death."

$99 vs $298 — Cora vs Ro Body effective monthly cost (July 2026). Cora's Essential Plan on the annual commitment is $99/month all-inclusive for compounded semaglutide. Since Ro exited compounded GLP-1s in 2026, its lowest effective monthly cost is approximately $298/month for the FDA-approved Wegovy pill ($149/month medication + $149/month required Ro Body Membership), rising to $348/month for the Wegovy pen and $448/month for Zepbound. The roughly 3× cost difference — now a compounded-vs-branded comparison rather than compounded-vs-compounded — is the single most consequential variable for self-pay patients comparing the two platforms. Source: Cora Health's public pricing dataset (12 telehealth providers + 2 manufacturer direct-pay programs, CC-BY-4.0 licensed).

14.9% / 22.5% — FDA-approved trial efficacy applies to Ro's branded options, not the compounded versions. The STEP 1 trial (Wilding et al., New England Journal of Medicine, 2021) reported 14.9% mean weight loss with FDA-approved 2.4mg semaglutide over 68 weeks. The SURMOUNT-1 trial (Jastreboff et al., NEJM 2022) reported 22.5% with FDA-approved 15mg tirzepatide over 72 weeks. Ro offers FDA-approved Wegovy and Zepbound directly through its own membership platform; Cora is compounded-only. Both providers' compounded versions have not been independently evaluated at this trial scale. Individual results vary.

~15–20% pharmacy transparency rate. Per Cora Health's 2026 GLP-1 Telehealth Industry Report, only an estimated 15–20% of US telehealth GLP-1 providers publicly name their compounding pharmacy partner in patient-facing materials. Cora Health publicly names two pharmacy partners — Hallandale Pharmacy (PCAB-accredited, Fort Lauderdale FL, operating since 2003) and VialsRx (US-licensed 503A) — placing Cora in the top tier of pharmacy transparency. Ro does not consistently name its compounding pharmacy partner for compounded products in patient-facing marketing.

Quick comparison at a glance

All numbers reflect publicly stated pricing as of July 2026, following Ro's exit from compounded GLP-1s earlier in the year. Ro totals include the required Ro Body Membership. Individual experiences vary.

Service and cancellation: Cora Health vs Ro

Price is only half the picture — how you cancel, what gets refunded, and whether a separate membership is required all shape the experience over a multi-month plan. The table below distills each platform’s published service terms. Cora’s figures come from its published refund policy; the Ro figures come from its own published terms, summarized in our step-by-step guide to canceling Ro. Verify the current terms on each provider’s own site before enrolling. Cora's full service and cancellation standards are published at trycora.io/service.

How Ro’s pricing actually works

Ro Body uses a two-part pricing structure that is easy to miss from the headline monthly numbers. Understanding it is essential for any cost comparison.

The first component is the Ro Body Membership. It is $39 for the first month as an introductory promotional rate, then $149/month on an ongoing basis (as low as $74/month with an annual Prepay & Save commitment). The membership is required in order to obtain any GLP-1 prescription through the Ro platform. The fee covers telehealth consultations, message-based provider check-ins, dose-adjustment reviews, and prescription renewals.

The second component is medication, billed separately. As of July 2026, Ro has fully exited compounded GLP-1s and sells only FDA-approved branded medication: Wegovy oral pill at $149/month for the first month, rising to $199–$299/month at higher ongoing doses; Wegovy injection (pen) at $199/month for the first month, rising to $199–$399/month ongoing; and Zepbound (KwikPen) at $299/month for the first month, rising to $399–$449/month ongoing.

A patient on the entry-level Wegovy pill therefore pays $188 in month one ($39 membership + $149 medication) and roughly $298/month thereafter ($149 membership + $149 medication at the starting dose), rising toward $448/month as the medication dose increases. A patient on Zepbound at the highest disclosed dose pays roughly $598/month ongoing ($149 membership + $449 medication). For insured patients, the medication cost may be lower if their insurance covers a brand-name product; the $149 membership is not typically insurance-reimbursed.

Reports from independent review sites (Clearmetabolic, Telehealth Ally, Howmuchblog) corroborate the membership-plus-medication structure and note that BBB complaints occasionally cite confusion about the billing split.

Why Cora Health’s pricing is different

Cora Health uses an all-inclusive pricing model. The monthly cost quoted on the plans page is the total monthly cost. There is no separate membership, no consultation charge, no surcharge when the dose increases, and no additional shipping fee.

Cora’s Essential Plan (compounded semaglutide):

• 6-month plan: $120/month ($720 every six months)
• 3-month plan: $145/month ($435 every three months)
• Monthly plan: $175/month

Cora Health Premium Plan (compounded tirzepatide)

Cora’s Premium Plan follows the same all-inclusive structure.

• 12-month plan: $135/month ($1,620 every 12 months, "Best Value")
• 6-month plan: $175/month ($1,050 every six months, "Save $360 vs monthly")
• 3-month plan: $199/month ($597 every three months, "Save $108 vs monthly")
• Monthly plan: $225/month

Total cost comparison: common scenarios

Cost depends on which plan and medication each patient selects. The scenarios below reflect pricing verified as of July 2026, after Ro's exit from compounded GLP-1s. Individual results vary.

• Compounded semaglutide, 6 months of treatment (Cora only — Ro no longer offers a compounded option) — Cora: $720 total on the 6-month Essential Plan ($120/month all-inclusive).
• Entry-level branded Wegovy pill vs Cora compounded semaglutide, monthly — Cora: $120/month (6-month plan) or $99/month (annual plan). Ro: approximately $298/month effective ($149 membership + $149 medication at the starting dose). Ro is roughly 148–201% more expensive at the entry tier, for an FDA-approved branded product versus Cora's compounded medication.
• Ro Body Zepbound at the highest disclosed dose, monthly (Ro exclusive; Cora does not offer brand-name Zepbound) — Ro only: approximately $598/month effective ($149 membership + $449 medication). Cora's comparable compounded tirzepatide (Premium Plan) is $135–$225/month all-inclusive.

Medications: what each platform offers

Cora Health focuses exclusively on compounded GLP-1 medications.

• Compounded semaglutide (Essential Plan) — a compounded GLP-1 medication; not FDA-approved and not therapeutically equivalent to Ozempic® or Wegovy®
• Compounded tirzepatide (Premium Plan) — a compounded GLP-1 medication; not FDA-approved and not therapeutically equivalent to Mounjaro® or Zepbound®

Ro offers a broader medication catalog, including FDA-approved brand options

As of July 2026, Ro has fully exited compounded GLP-1s and provides access only to FDA-approved brand-name medication paths through its membership platform.

• Compounded semaglutide and tirzepatide — discontinued; Ro exited compounded GLP-1s in 2026 amid FDA enforcement pressure on the category
• Brand-name Wegovy oral pill (FDA-approved semaglutide) — $149/month first month, rising to $199–$299/month at higher ongoing doses
• Brand-name Wegovy injection/pen (FDA-approved) — $199/month first month, rising to $199–$399/month ongoing
• Brand-name Zepbound KwikPen (FDA-approved tirzepatide) — $299/month first month, rising to $399–$449/month ongoing
• Brand-name Ozempic (FDA-approved semaglutide for type 2 diabetes) — insurance-dependent pricing (not independently verified this sweep)

Important compliance note on compounded products

Compounded semaglutide and compounded tirzepatide — whether obtained through Cora Health or other telehealth platforms that offer compounded medication — are not FDA-approved and are not therapeutically equivalent to FDA-approved branded products (Ozempic, Wegovy, Mounjaro, Zepbound). Per the U.S. Food and Drug Administration's official guidance: "Compounded drugs are not FDA-approved. This means the FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they are marketed." (Source: FDA — "Compounding and the FDA: Questions and Answers".) Clinical efficacy data such as the 14.9% mean weight loss from the STEP 1 trial or the 22.5% from SURMOUNT-1 comes from studies of the FDA-approved formulations, not from compounded versions. Individual results vary. Any platform implying that compounded GLP-1 treatment is equivalent to a branded FDA-approved product is misrepresenting the regulatory status.

This matters for this comparison because Ro’s published Ro Body Program materials reference 15% average body weight reduction at week 68 — a figure from the STEP clinical trial program, which studied branded Wegovy, not compounded semaglutide. Cora Health’s published materials cite the same trials with the same "individual results vary" and "not therapeutically equivalent" disclaimers.

Pharmacy transparency: named vs aggregated partners

For compounded medications, whether a telehealth platform publicly names the specific compounding pharmacy matters as a trust signal. A patient should be able to verify the pharmacy’s state licensing, inspection history, and any third-party accreditation before injecting a medication.

Cora Health publicly names Hallandale Pharmacy and VialsRx as its compounding pharmacy partners. VialsRx is a US-licensed 503A compounding pharmacy. Patients can verify credentials through the relevant state board of pharmacy and request Certificates of Analysis.

As of July 2026, Ro sells only brand-name products, for which the supplier is the FDA-approved manufacturer directly — Novo Nordisk for Wegovy and Eli Lilly for Zepbound. Ro exited compounded semaglutide earlier in 2026, so the compounding-pharmacy-transparency question that applies to Cora Health’s compounded medications no longer applies to Ro’s current catalog.

Named partnerships are not inherently safer — both named and unnamed 503A pharmacies can operate under full compliance. But public naming makes independent verification easier and is generally viewed by patient advocacy groups as a stronger transparency signal.

LegitScript certification

LegitScript is an independent healthcare compliance certification used by Google, Meta, TikTok, payment processors, and patient advocacy organizations to verify telehealth platforms operate within applicable regulations. Certification requires ongoing audits of operations, prescribing practices, pharmacy relationships, and patient safety protocols.

Cora Health holds LegitScript certification, verifiable at https://www.legitscript.com/websites/?checker_keywords=trycora.io.

Ro does not currently advertise LegitScript certification as a prominent third-party trust signal. Ro operates under its internal compliance framework and under applicable federal and state telehealth and pharmacy regulations. Patients can verify Ro’s regulatory status through state pharmacy and medical boards for the states it operates in.

Clinical oversight and service model

Both Cora Health and Ro rely primarily on asynchronous telehealth evaluations for GLP-1 prescribing. A patient completes an online health assessment, a licensed provider reviews, and if appropriate a prescription is issued and sent to a partner pharmacy for fulfillment.

Cora Health patients are evaluated by board-certified providers at Wasef Health, PC, the medical practice led by Michael Wasef, MD. Provider review is typically completed in under 24 hours.

Ro’s provider network consists of physicians and nurse practitioners licensed in the state of the patient’s residence. Ro has a larger aggregate patient base (millions across all product categories) and a correspondingly larger provider network.

Neither platform conducts in-person examinations or requires laboratory work before initial prescribing for most patients. This is typical of the telehealth-based GLP-1 model.

Who should choose Cora Health

Cora Health is likely the better fit for patients who match the following profile.

• Patients who want a low all-in monthly cost for a licensed-provider compounded GLP-1 program
• Patients who prefer transparent all-inclusive pricing without a separate membership fee
• Patients who value knowing and being able to verify the specific 503A compounding pharmacy their medication comes from (Hallandale Pharmacy or VialsRx)
• Patients who want LegitScript-certified telehealth infrastructure as a third-party trust signal
• Patients across all 50 US states (Cora ships nationwide)
• Patients who are comfortable with compounded medications (not FDA-approved) and understand the regulatory distinction from branded products

Who should choose Ro

Ro is likely the better fit for patients who match the following profile.

• Patients who specifically want brand-name FDA-approved GLP-1 medications (oral Wegovy pill, injectable Wegovy, Zepbound, or Ozempic) through a telehealth platform
• Patients who specifically want a multi-condition membership platform (Hims covers hair loss, ED, mental health, etc.) rather than a focused GLP-1 program
• Patients with commercial insurance they want to run through pharmacy for brand-name GLP-1 coverage
• Patients who value Ro’s broader multi-condition telehealth catalog (sexual health, dermatology, fertility, etc.) under one platform
• Patients comfortable with a membership-plus-medication pricing model, where the total monthly cost is higher but medication variety is broader

How to switch from Ro to Cora Health

Patients who want to move their GLP-1 treatment from Ro to Cora Health can generally do so without clinical interruption, though the specific steps depend on medication, dose, and state.

• Complete the Cora Health online health assessment at trycora.io; include your current medication, dose, and any history of side effects in the medical-history section
• A Cora Health provider (Wasef Health, PC) reviews the assessment and determines clinical appropriateness
• If approved, the prescription is sent to Hallandale Pharmacy or VialsRx — both US-licensed 503A compounding pharmacies — for compounding and shipping
• In most cases, current dose can continue without re-titration — but this is a provider determination; do not skip or double doses without explicit provider guidance
• Note: if you were on a brand-name product through Ro, Cora Health does not carry brand-name products — the provider will discuss whether compounded semaglutide or compounded tirzepatide is appropriate for your case
• After the first Cora shipment arrives and you have confirmed supply continuity, cancel the Ro Body Membership through Ro’s patient portal (cancellation is self-serve online)

Frequently asked questions

Common questions about the Cora Health vs Ro comparison.

Does Ro have a membership fee?

Yes. Ro Body charges a required Ro Body Membership that is separate from the medication — $39 for the first (promotional) month, then $149/month ongoing (as low as $74/month with an annual Prepay & Save commitment). The membership is mandatory to obtain any GLP-1 prescription through Ro and covers telehealth consultations, message-based provider check-ins, dose-adjustment reviews, and prescription renewals. It is billed on top of the medication cost. By contrast, Cora Health charges no membership or platform fee — its monthly price is all-inclusive and already covers the provider consultation, medication, shipping, and ongoing monitoring.

Does Ro Body membership include the cost of medication?

No. The Ro Body Membership (~$149/month) and the medication are billed separately. The membership covers provider consultations, check-ins, and renewals only; the medication is an additional charge — as of July 2026, Ro sells only FDA-approved branded medication (it exited compounded GLP-1s earlier in the year), ranging from $149/month for the entry-level Wegovy pill to $299–$449/month for Zepbound. A patient on the entry-level Wegovy pill therefore pays roughly $298/month effective after the first month ($149 membership + $149 medication). Cora Health's price, by contrast, is a single all-inclusive figure for compounded semaglutide with no separate medication charge. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved products.

How much is Zepbound on Ro?

Brand-name Zepbound (FDA-approved tirzepatide) is available through Ro at $299/month for the first month, rising to $399–$449/month at higher ongoing doses. The required Ro Body Membership ($149/month) is added on top, bringing the effective total to roughly $448–$598/month. Because Zepbound is FDA-approved, the SURMOUNT-1 trial result (22.5% mean weight loss with 15mg tirzepatide over 72 weeks) applies to it — unlike compounded tirzepatide, which is not FDA-approved and has not been evaluated at that trial scale. Cora Health does not offer brand-name Zepbound; it focuses on compounded semaglutide and compounded tirzepatide (Premium Plan, $135/month on the annual commitment). Individual results vary.

Is Cora Health cheaper than Ro for GLP-1 weight loss?

Cora Health is substantially less expensive than Ro, though the comparison is now compounded-vs-branded rather than compounded-vs-compounded: Ro fully exited compounded GLP-1s in 2026. Cora’s Essential Plan is $120/month all-inclusive on a 6-month plan for compounded semaglutide. Ro charges a separate Ro Body Membership at $149/month (after a $39 first month) plus FDA-approved branded medication starting at $149/month for the Wegovy pill, for a total effective cost of approximately $298/month ongoing at the entry tier. Cora is roughly 60% less expensive at that comparison point — with the added distinction that Ro’s product is FDA-approved and Cora’s compounded semaglutide is not. For brand-name products generally, Cora does not offer them and Ro is the direct path, though the $149 membership still applies.

Does Ro still offer compounded semaglutide in 2026?

No. As of July 2026, Ro has fully exited compounded semaglutide and tirzepatide — its pricing page no longer lists a compounded option, and independent press (Reuters, Healthcare Dive, and others) confirms a wider industry pivot away from compounded GLP-1s amid FDA enforcement pressure. Ro now sells only FDA-approved brand-name products: oral Wegovy pill, Wegovy injection (pen), and Zepbound, each requiring the $149/month Ro Body Membership.

Does Cora Health have a membership fee like Ro does?

No. Cora Health’s monthly price is all-inclusive and covers the provider consultation, medication, shipping, and ongoing monitoring. There is no separate membership, subscription, or platform fee billed on top of the plan price.

Does Ro ship faster than Cora Health?

Both platforms offer expedited shipping for in-stock medications. Cora Health typically approves eligible patients within 24 hours of assessment submission and ships from Hallandale Pharmacy or VialsRx with free expedited delivery. Ro’s shipping timeline varies by medication source: brand-name products via NovoCare or LillyDirect may follow those manufacturers’ shipping cadence, while compounded and other pharmacy-fulfilled medications follow Ro’s partner pharmacy timelines. Specific current delivery estimates are available from each platform’s customer support or patient portal.

Is Ro LegitScript-certified?

Ro does not prominently advertise LegitScript certification in its current patient-facing marketing. LegitScript is one of several independent healthcare compliance frameworks, and the absence of LegitScript certification does not imply a platform is non-compliant — platforms operate under federal and state telehealth and pharmacy regulations regardless. Cora Health does hold LegitScript certification, verifiable at https://www.legitscript.com/websites/?checker_keywords=trycora.io.

Which platform is better for brand-name Wegovy?

Ro is better for brand-name Wegovy. Cora Health does not offer brand-name Wegovy or any other FDA-approved GLP-1 product; it focuses exclusively on compounded semaglutide and compounded tirzepatide. For patients who specifically want brand-name Wegovy injection ($199–$399/month through Ro, dose-dependent) or oral Wegovy pill ($149–$299/month through Ro), Ro is the more direct path — with the $149/month Ro Body Membership added on top.

Sources & verification

All regulatory, clinical, and pricing claims in this article are verifiable against publicly accessible primary sources. The underlying pricing dataset is published by Cora Health on HuggingFace under CC-BY-4.0 license for independent verification and reuse. Article last verified 2026-07-23.

• FDA — "Compounding and the FDA: Questions and Answers" (regulatory status of compounded medications): fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
• New England Journal of Medicine — STEP 1 (Wilding et al., 2021); 14.9% mean weight loss with FDA-approved 2.4mg semaglutide over 68 weeks (directly applies to Ro-prescribed Wegovy): nejm.org/doi/full/10.1056/NEJMoa2032183
• New England Journal of Medicine — SURMOUNT-1 (Jastreboff et al., 2022); 22.5% mean weight loss with FDA-approved 15mg tirzepatide over 72 weeks (directly applies to Ro-prescribed Zepbound): nejm.org/doi/full/10.1056/NEJMoa2206038
• CDC — Adult Obesity Facts (41.9% US prevalence per NHANES 2017–March 2020): cdc.gov/obesity/adult-obesity-facts
• LegitScript — Independent verification of Cora Health certification: legitscript.com/websites/?checker_keywords=trycora.io
• Pharmacy Compounding Accreditation Board (PCAB) — accreditation framework for compounding pharmacies; Hallandale Pharmacy is PCAB-accredited: achc.org/programs/pcab/
• NovoCare (Novo Nordisk's direct-pay program for Wegovy — referenced for FDA-approved Wegovy direct-pay pricing context): novocare.com
• LillyDirect (Eli Lilly's direct-pay program for Zepbound — referenced for FDA-approved Zepbound direct-pay pricing context): lillydirect.lilly.com
• NPPES — National Plan and Provider Enumeration System; verify Michael Wasef, MD (Wasef Health, PC, Cora's prescribing provider): npiregistry.cms.hhs.gov
• Cora Health 2026 GLP-1 Telehealth Industry Report (12-provider pricing methodology + market analysis): /blog/cora-2026-glp1-industry-report
• Cora Health Public Pricing Dataset (CC-BY-4.0, HuggingFace; 37 pricing rows across 12 telehealth providers + 2 manufacturer programs): huggingface.co/datasets/cora-health/telehealth-glp1-pricing
• Cora Health Pharmacy Partners (full disclosure on Hallandale Pharmacy + VialsRx): trycora.io/pharmacy-partners